Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
821 10 |
Ultima descărcare din IBN: 2023-06-03 18:06 |
Căutarea după subiecte similare conform CZU |
314.424:616-006.04(478)"2012-2017" (1) |
Demografie. Studiul populației (832) |
Patologie. Medicină clinică (7211) |
SM ISO690:2012 BURUIANA, Sanda. Mortalitatea prin hemoblastoze în Republica Moldova în perioada anilor 2012-2017. In: Revista ştiinţifico-practică ”Info-Med” , 2018, nr. 2(32), pp. 65-68. ISSN 1810-3936. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Revista ştiinţifico-practică ”Info-Med” | ||||||
Numărul 2(32) / 2018 / ISSN 1810-3936 | ||||||
|
||||||
CZU: 314.424:616-006.04(478)"2012-2017" | ||||||
Pag. 65-68 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Cancer is a major risk of public health both globally, regionally and nationally. In the republic of Moldova (RM) cancer represents the same paternity specific to the globally one and is ranked second among the leading causes of death of the population [1, 2]. It also occupied the second-highest position among causes of mortality in children up to 15 years of age [3]. According to dates from the National Health Management Center of the ministry of Health, the mortality structure according to the causes of death actually did not change during the period 2012-2017: most deaths are due to the diseases of the circulatory system, followed by tumors, digestive diseases, accidents, intoxications and trauma, diseases of the respiratory system [4]. Hemoblastoses are malignant tumors that develop from hematopoetic tissue cells [5]. We differ in leukemia and lymphoma [6]. These two groups of hemoblastoses differ in clinical progression, treatment, prognosis and morbidity, mortality. Childhood hemoblastses accounts for 50% of all malignant tumors at this age, and acute leukemia accounts for one third of all malignant tumors (30 cases per 1 million inhabitants) with maximum development at 2-5 years of age [7]. |
||||||
Cuvinte-cheie mortalitate, hemoblastoze, hemoblastosis, cancer, mortality, cancer |
||||||
|
Dublin Core Export
<?xml version='1.0' encoding='utf-8'?> <oai_dc:dc xmlns:dc='http://purl.org/dc/elements/1.1/' xmlns:oai_dc='http://www.openarchives.org/OAI/2.0/oai_dc/' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd'> <dc:creator>Buruiana, S.</dc:creator> <dc:date>2018-12-01</dc:date> <dc:description xml:lang='en'><p>Cancer is a major risk of public health both globally, regionally and nationally. In the republic of Moldova (RM) cancer represents the same paternity specific to the globally one and is ranked second among the leading causes of death of the population [1, 2]. It also occupied the second-highest position among causes of mortality in children up to 15 years of age [3]. According to dates from the National Health Management Center of the ministry of Health, the mortality structure according to the causes of death actually did not change during the period 2012-2017: most deaths are due to the diseases of the circulatory system, followed by tumors, digestive diseases, accidents, intoxications and trauma, diseases of the respiratory system [4]. Hemoblastoses are malignant tumors that develop from hematopoetic tissue cells [5]. We differ in leukemia and lymphoma [6]. These two groups of hemoblastoses differ in clinical progression, treatment, prognosis and morbidity, mortality. Childhood hemoblastses accounts for 50% of all malignant tumors at this age, and acute leukemia accounts for one third of all malignant tumors (30 cases per 1 million inhabitants) with maximum development at 2-5 years of age [7].</p></dc:description> <dc:source>Revista ştiinţifico-practică ”Info-Med” 32 (2) 65-68</dc:source> <dc:subject>mortalitate</dc:subject> <dc:subject>hemoblastoze</dc:subject> <dc:subject>hemoblastosis</dc:subject> <dc:subject>cancer</dc:subject> <dc:subject>mortality</dc:subject> <dc:subject>cancer</dc:subject> <dc:title>Mortalitatea prin hemoblastoze în Republica Moldova în perioada anilor 2012-2017</dc:title> <dc:type>info:eu-repo/semantics/article</dc:type> </oai_dc:dc>